Zepp Health Corporation Sponsored ADR

ZEPP Technology Consumer Electronics

Zepp Health Corporation Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $258.9 million, up 41.8% from fiscal 2024.

Revenue
+6.93%
EPS
−46.9%
Free cash flow
−103.7%
Total debt
+26.4%

Quarter to June 2026, against a year earlier

2.40 0.18 +8.11%
Market cap
$18.8M
P/E
0.0×
Fwd P/E
−22.0×
Dividend yield
—
F-score
5/9
Altman Z
1.01
Beneish M
−2.49
Dividend safety
n/a

Insider Decisions last twelve months

Sold, $m 0.09
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell — — — — — — 1 — — 1 — —
Insider Ownership 46.51%

Capital & Financial Ratios $m

Size
Market Cap 18.83
Revenue ttm 276.03
Net income ttm (40.07)
Free cash flow ttm (11.76)
Net debt Q 26.97
Valuation
P/E 0.00
Forward P/E (22.00) (negative: loss-making)
Price / sales 0.13
Forward P/S Powerpack
Price / FCF 0.00
Price / book 0.19
Financial health
Current ratio Q 0.90 (below 1: weak)
Debt / equity Q 0.72
Interest coverage Q (7.33)
Growth
Revenue growth Q +6.93% (above 0%: growing)
Operating income growth Q −101.72% (below 0%: shrinking)
EPS, this year +16.67% (at or above 15%: strong)
EPS, next year A +60.00% (at or above 15%: strong)
Revenue, next year A +687.96% (at or above 10%: strong)
EPS, past 5 yrs —
EPS, next 5 yrs A +8.71%

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

P/S against its own 10 years 4.62%
10-year low 10-year high
P/B against its own 10 years 16.41%
10-year low 10-year high
EV/Sales against its own 10 years 16.21%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 146 112 113 106
Receivables 69 66 74 83
Inventory 85 57 73 62
Other — — — —
317 252 294 283
2023 2024 2025 Q'26
Payables 37 51 81 88
ST’ Debt 2 42 56 77
Other 0 0 0 0
155 195 287 314

Compound Annual Growth %

10y 5y 3y
Sales — (23.47%) (24.46%)
Cash Flow — 0.00% 0.00%
Earnings — 0.00% 0.00%
Book Value — (12.51%) (18.01%)

EPS $

Mar Jun Sep Dec Year
’26 (1.24) (0.72) — — —
’25 (1.23) (0.49) (0.10) (0.69) (2.52)
’24 (0.92) (0.68) (0.82) (2.29) (4.68)
’23 (1.28) (0.64) 0.02 (0.08) (1.96)
’22 (0.88) (1.04) (0.16) (0.72) (2.72)
’21 (0.40) 0.88 0.44 0.09 1.32
’20 0.16 0.12 0.72 1.08 2.16
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 52 64 — — —
’25 39 59 76 85 259
’24 40 41 42 60 183
’23 94 92 83 83 353
’22 119 165 170 146 601
’21 175 284 249 260 981
’20 154 161 329 342 986
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 — — — — —
’25 — — — (26) (26)
’24 — — — (24) (24)
’23 — — — — 43
’22 — — — — (114)
’21 — — — — (36)
’20 — — — — 24
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 — — — — —
’25 — — — (26) (26)
’24 — — — (25) (24)
’23 — — — 0 46
’22 — — — (1) (116)
’21 — — — — (44)
’20 — — — (13) 11
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Jun ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 234 315 530 835 986 981 601 353 183 259 276 +1.1% 2,040 2,172 2,121 +101.6%
Gross margin, % 17.74 24.14 25.77 25.25 20.71 20.89 19.39 26.17 38.46 38.31 38.58 +20.6 pt
EBT 4 29 56 94 41 17 (54) (35) (58) (35) (39) n/m
EBT margin, % 1.85 9.37 10.61 11.22 4.13 1.71 (8.99) (9.81) (31.71) (13.70) (14.01) (15.5) pt
Net income 4 26 49 82 35 21 (42) (31) (76) (40) (40) n/m
Per share, $
Per share, $ Revenue 67.31 74.34 40.04 54.83 63.49 62.23 39.02 23.22 11.29 16.28 17.43 (14.6%)
Earnings (0.52) 1.68 1.25 5.40 2.24 1.36 (2.72) (1.96) (4.68) (2.52) (2.75) +19.1%
Cash flow 0.75 8.65 7.77 4.04 1.55 (2.31) (7.42) 2.80 (1.51) (1.62) 0.00 n/m
Capex (0.50) (0.78) (0.76) (0.43) (0.84) (0.50) (0.09) 0.20 0.02 (0.01) 0.00 (33.9%)
Free cash flow 0.25 7.87 7.01 3.60 0.72 (2.82) (7.51) 3.00 (1.49) (1.63) 0.00 n/m
Book value 1.30 8.28 19.88 23.56 26.94 29.21 25.29 23.21 15.62 13.49 11.68 +29.6%
Shares, m 3 4 13 15 16 16 15 15 16 16 16 +18.4%
Valuation, ×
Valuation, × P/E 0.00 0.13 11.54 8.97 21.94 19.80 0.00 0.00 0.00 0.00 0.00 6.2
P/S 0.00 0.00 0.98 0.88 0.75 1.32 0.16 0.25 0.23 1.65 0.13 0.6
P/B 0.00 0.02 1.98 2.04 1.76 2.79 0.25 0.25 0.17 2.00 0.19 1.1
EV/Sales 0.00 0.00 0.54 0.58 0.48 1.28 0.32 0.18 0.26 1.66 0.23 0.5
EV/FCF 0.00 0.00 2.14 2.56 3.10 8.17 4.52 (15.95) 12.75 (36.61) (5.35) (1.9)
Cash, $m
Cash, $m Operating cash flow 3 37 103 61 24 (36) (114) 43 (24) (26) (13) n/m
Capex (2) (3) (10) (7) (13) (8) (1) 3 0 0 2 (21.8%)
Free cash flow 1 33 93 55 11 (44) (116) 46 (24) (26) (12) n/m
Balance, $m
Balance, $m Working capital 34 64 214 274 312 279 187 162 56 7 (32) (16.5%)
Net debt (23) (53) (227) (246) (259) (40) 99 (24) 5 2 27 n/m
Shareholders’ equity 5 35 263 359 418 460 389 353 253 215 185 +53.5%
Returns, %
Returns, % ROA (0.98) 3.82 4.72 13.52 4.25 2.33 (4.86) (4.43) (13.01) (7.33) (7.86) (6.3) pt
ROIC 0.00 0.00 91.68 48.12 10.44 2.19 (7.62) (5.79) (11.44) (8.43) (10.25) (8.4) pt
ROE (9.29) 35.79 11.07 26.46 9.02 4.92 (9.84) (8.36) (25.02) (17.15) (21.23) (7.9) pt
People
People Employees 376 416 694 1,132 1,507 1,227 987 839 765 763 — +8.2%
Revenue/emp, $m 0.62 0.76 0.76 0.74 0.65 0.80 0.61 0.42 0.24 0.34 — (6.5%)
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026 · fundamentals updated 26 Oct 2026

Zepp Health Corporation Sponsored ADR vs peers in Consumer Electronics (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
FXHO UTime Limited $156.0M — (loss-making) — +1.06% (above 0%: growing) n/m −341.47% (below 0%: shrinking) 23.95% 0.00% Compare
UEIC Universal Electronics Inc. $62.6M — (loss-making) — (loss-making) −1.25% (below 0%: shrinking) n/m +13.81% (above 0%: growing) 26.34% 3.19% Compare
AXIL AXIL Brands, Inc. $35.4M 13.3× — −11.17% (below 0%: shrinking) +20.00% (above 0%: growing) +531.52% (above 0%: growing) 82.62% 7.18% Compare
KOSS Koss Corporation $28.7M — (loss-making) 53.5× −23.99% (below 0%: shrinking) n/m −227.85% (below 0%: shrinking) 39.49% (12.95%) Compare
ZEPP Zepp Health Corporation Sponsored ADR $18.8M — (loss-making) — (loss-making) +6.93% (above 0%: growing) n/m −103.70% (below 0%: shrinking) 37.35% (19.37%)
FOXX Foxx Development Holdings Inc. $13.0M — (loss-making) — −49.92% (below 0%: shrinking) n/m +11.09% (above 0%: growing) (26.08%) (97.68%) Compare
FEBO Fenbo Holdings Limited $7.1M — — — — −82.70% (below 0%: shrinking) — — Compare
MSN Emerson Radio Corporation $6.2M — (loss-making) 21.5× −37.07% (below 0%: shrinking) n/m −66.15% (below 0%: shrinking) 49.34% (65.09%) Compare
WLDS Wearable Devices Ltd. $3.2M — (loss-making) — −88.79% (below 0%: shrinking) n/m −9.83% (below 0%: shrinking) (116.67%) 0.00% Compare
Median of peers $20.8M — — −23.99% — −37.99% 26.34% 0.00%

All 19 Consumer Electronics stocks →

Zepp Health Corporation Sponsored ADR (ZEPP) Latest News

19 Apr

20 Feb

Impact 4 · · ACCESS NewswireReutersMotley FoolProactive

6 Jan

19 Oct

stockrow.com/ZEPP · Data as of Oct 26, 2026 · For information only; not investment advice. · © 2026 stockrow.com